XBiotech Inc is a biopharmaceutical company that discovers and develops True Human monoclonal antibodies derived from human donors to replicate the human immune response in the treatment of various diseases. It has developed a pipeline of product candidates using True Human antibodies targeting both inflammatory and infectious diseases. The company's developement pipeline comprises: Natrunix, an antibody targeting IL-1a in oncology (pancreatic cancer), a clinical stage therapeutic for Methicillin Resistant Staphylococcus aureus (MRSA), and several pre-clinical stage therapeutics, including: an oral delivery antibody therapeutic for colon infection by C. difficile; an injectable therapy for varicella zoster (adult chicken pox), the causative agent for shingles; and an influenza therapy.
No Form 4 activity for XBIT in the last 90 days.
4 Form 4 filings on record, the earliest from Nov 12, 2025, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Craig Evan Rademaker | Grant or award | Director Stock Option | 92,104 | $0.00 | - | |
| David Spencer Soffer | Grant or award | Director Stock Option | 51,000 | $0.00 | - | |
| Thomas Martin Kuendig | Grant or award | Director Stock Option | 79,115 | $0.00 | - | |
| Tevi David Troy | Grant or award | Director Stock Option | 56,000 | $0.00 | - |
XBiotech Inc. (XBIT) has filed no insider reports in the last 90 days. The most recent on record is dated 2025-11-12. The full record for XBIT runs to 4 Form 4 filings, the earliest from 2025-11-12. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of XBIT were filed in the last 90 days.
No insider sales of XBIT were filed in the last 90 days.
This page tracks XBIT Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add XBIT to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.